C 13 H14N 2 O, monoclinic, P21/c (no. 14), a = 9.933(2) Å,
.
Source of material
The title compound was synthesized by 1-benzyl-3-cyano-1,4-dihydropyridine under irradiation of UV-light in methanol solution. After approximately 24 h, followed by thinlayer chromatography, the residue was puri ed by ash chromatography using ethyl acetate-petroleum ether (1:10 v/v). After concentration in vacuo, colorless solids were collected and dried, and recrystallized from THF. After 3 days colorless crystals suitable for X-ray di raction were obtained.
Experimental details
All H atoms were placed in idealized positions (C-H = 0.93-0.98 Å, O-H = 0.82 Å) and re ned as riding atoms. The U iso values were constrained to be 1.5Ueq of the carrier atom for oxygen H atoms and 1.2Ueq for the remaining H atoms. Pseudo-merohedral twinning in the crystal was identi ed [TwinRotMat [8] ; twin law −1 0 0, 0 −1 0, 0 0 1] giving a nal twin ratio of 0.500(1)/0.500(1).
Discussion
Tetrahydropyridines are a class of interesting compounds because they play important roles in synthetic, therapeutic, and bioorganic chemistry [1] [2] [3] [4] [5] [6] . In order to search for new tetrahydropyridines, the title compound was synthesized and its crystal structure determined. The asymmetric unit of the title compound consists of two independent and conformationally similar molecules. All bond lengths and angles are in the expected ranges. The tetrahydro-pyridine ring adopts a half-chair conformation. In the crystal, O-H· · · N hydrogen bonds generate chains along the a-axis direction.
